Physician profile
Kevin Su
NPI 1336791524
$4,104.34
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $715 · 2020: $367 · 2021: $419 · 2022: $330 · 2023: $2,170 · 2024: $103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,150 · Travel and Lodging: $878 · Education: $246.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,150.27 |
| Travel and Lodging | $877.60 |
| Education | $245.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $3,668.86 | 2019-2023 | |
| Ormco Corporation | $128.91 | 2021-2022 | |
| Align Technology, INC. | $121.37 | 2021 | |
| Dentsply Sirona INC | $73.32 | 2023-2024 | Primescan Connect, Tph Spectra Universal Composite Restorative Low Viscosity, Suresmile |
| Orapharma, A Division of Bausch Health US, LLC | $25.73 | 2024 | Arestin |
| American Orthodontics Corporation | $20.68 | 2024 | Master Series, LP and Ifit Tubes, Radiance |
| Voco America INC. | $18.53 | 2023 | Grandio Blocs, Grandio So, Voco Profluorid Varnish |
| Zest Holdings, LLC | $17.80 | 2024 | |
| Kerr Corporation | $14.57 | 2023 | Optibond Solo Plus |
| Nobel Biocare USA | $14.57 | 2023 | Nobelactive |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Su listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.